Procept Biorobotics Corp
NASDAQ:PRCT
Balance Sheet
Balance Sheet Decomposition
Procept Biorobotics Corp
Procept Biorobotics Corp
Balance Sheet
Procept Biorobotics Corp
| Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|
| Assets | |||||||
| Cash & Cash Equivalents |
42
|
100
|
304
|
222
|
251
|
334
|
|
| Cash |
0
|
0
|
14
|
9
|
0
|
11
|
|
| Cash Equivalents |
42
|
100
|
291
|
213
|
251
|
323
|
|
| Total Receivables |
1
|
2
|
5
|
15
|
48
|
83
|
|
| Accounts Receivables |
1
|
2
|
5
|
15
|
48
|
83
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Inventory |
7
|
8
|
14
|
29
|
40
|
56
|
|
| Other Current Assets |
1
|
1
|
3
|
7
|
5
|
8
|
|
| Total Current Assets |
51
|
110
|
326
|
273
|
351
|
482
|
|
| PP&E Net |
8
|
13
|
8
|
32
|
49
|
46
|
|
| PP&E Gross |
8
|
13
|
8
|
32
|
49
|
46
|
|
| Accumulated Depreciation |
2
|
5
|
7
|
9
|
4
|
8
|
|
| Intangible Assets |
2
|
2
|
2
|
2
|
1
|
1
|
|
| Other Long-Term Assets |
1
|
1
|
1
|
3
|
4
|
6
|
|
| Total Assets |
62
N/A
|
126
+103%
|
337
+167%
|
309
-8%
|
405
+31%
|
534
+32%
|
|
| Liabilities | |||||||
| Accounts Payable |
1
|
1
|
2
|
9
|
13
|
10
|
|
| Accrued Liabilities |
3
|
8
|
11
|
21
|
22
|
28
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
5
|
0
|
0
|
0
|
0
|
|
| Other Current Liabilities |
2
|
1
|
3
|
5
|
10
|
15
|
|
| Total Current Liabilities |
7
|
15
|
16
|
35
|
46
|
53
|
|
| Long-Term Debt |
23
|
44
|
50
|
51
|
51
|
51
|
|
| Other Liabilities |
3
|
6
|
4
|
26
|
27
|
27
|
|
| Total Liabilities |
33
N/A
|
65
+98%
|
70
+8%
|
112
+61%
|
124
+10%
|
132
+6%
|
|
| Equity | |||||||
| Common Stock |
173
|
244
|
0
|
0
|
0
|
0
|
|
| Retained Earnings |
149
|
202
|
262
|
349
|
455
|
546
|
|
| Additional Paid In Capital |
5
|
19
|
529
|
546
|
735
|
948
|
|
| Unrealized Security Profit/Loss |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Equity |
29
N/A
|
61
+109%
|
267
+338%
|
197
-26%
|
281
+42%
|
402
+43%
|
|
| Total Liabilities & Equity |
62
N/A
|
126
+103%
|
337
+167%
|
309
-8%
|
405
+31%
|
534
+32%
|
|
| Shares Outstanding | |||||||
| Common Shares Outstanding |
42
|
42
|
44
|
45
|
51
|
55
|
|